Functional Electrical Stimulation (FES) Driven Stepping in Individuals With Spinal Cord Injury
FES Driven Stepping in Individuals With Spinal Cord Injury
1 other identifier
interventional
12
1 country
1
Brief Summary
The research is being done to find out if Functional Electrical Stimulation (FES) stepping can improve the function of people with spinal cord injury that paralyzes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Apr 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 15, 2011
CompletedFirst Posted
Study publicly available on registry
November 24, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedResults Posted
Study results publicly available
September 15, 2014
CompletedSeptember 15, 2014
September 1, 2014
1 year
November 15, 2011
August 1, 2013
September 9, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Motor and Sensory Scores of the ASIA Impairment Scale (AIS)
Change in motor, pin prick, and light touch score components of the ASIA Impairment scale (AIS) after 8 weeks of stepping FES in persons with spinal cord injury. The AIS evaluates motor and sensory function and comprises motor (min 0, max 100), pin prick (min 0, max 112), and light touch (min 0, max 112) scores. Higher scores represent better functional outcome. AIS Classificatrion: A = Complete: No motor or sensory function is preserved in the sacral segments S4-S5. B = Incomplete: Sensory but not motor function is preserved below the neurological level and includes the sacral segments S4-S5. C = Incomplete: Motor function is preserved below the neurological level, and more than half of key muscles below the neurological level have a muscle grade less than 3. D = Incomplete: Motor function is preserved below the neurological level, and at least half of key muscles below the neurological level have a muscle grade of 3 or more. E = Normal: motor and sensory function are normal.
Baseline, 8 weeks
Secondary Outcomes (6)
Change in Heart Rate
Baseline, 8 weeks
Change in Systolic Blood Pressure
Baseline, 8 weeks
Change in Diastolic Plood Pressure
Baseline, 8 weeks
Change in Rate of Perceived Exertion
Baseline, 8 weeks
Change in Vital Capacity
Baseline, 8 weeks
- +1 more secondary outcomes
Study Arms (1)
FES Stepping
EXPERIMENTALFor the next 8 weeks, we will ask you to come to the ICSCI twice (2) time per week during which you will perform FES Stepping.
Interventions
You will be transferred to the RT600 device and secured in a support harness. We will place your legs onto the RT600 device and secure them with straps. Electrodes (pads that stick to the skin) will be placed on your skin on your legs, buttock, stomach, and back. The pads will be connected to a stimulator box through a wire. We will then start the stepping motor and stimulate your muscles with electric current. This will cause your legs to step. You will do this for 1 hour.
Eligibility Criteria
You may qualify if:
- Male, Female, age 18-65, all ethnic groups
- Spinal Cord Injury, traumatic and non-traumatic
- C1-T12 neurological level
- ASIA class A-D
- Chronic injury \> 6 months from the injury
- Visible motor response to FES stimulation (visible muscle contraction evoked with electrical stimulation)
- Subjects are medically stable, with no recent (1 month or less) inpatient admission for acute medical or surgical issues
- Subjects are able to comply with procedures and follow-up
You may not qualify if:
- Concurrent lower motor neuron disease such as peripheral neuropathy that would exclude lower extremity electrical excitability
- History of inability to tolerate electrical stimulation
- Cardiovascular disease as defined by previous myocardial infarction, unstable angina, requirement for anti platelet agents, congestive heart failure, or stroke NYHA Class III or IV, history of arrhythmia with hemodynamic instability
- Uncontrolled hypertension (resting systolic BP \> 160mmHg or diastolic BP \>100mmHg consistently)
- Presence of a pacemaker, an implanted defibrillator or certain other implanted electronic or metallic devices other than baclofen pumps
- Unstable long bone fractures of the lower extremities
- Presence of stage III or greater skin ulcerations that would preclude application of stimulating pads
- Malignancy
- History of epileptic seizures
- Women who are pregnant
- Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements
- Fractures less than 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kennedy Krieger Institute
Baltimore, Maryland, 21205, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Cristina Sadowsky
- Organization
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Cristina L Sadowsky, MD
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor Physical Medicine and Rehabilitation
Study Record Dates
First Submitted
November 15, 2011
First Posted
November 24, 2011
Study Start
April 1, 2011
Primary Completion
April 1, 2012
Study Completion
April 1, 2012
Last Updated
September 15, 2014
Results First Posted
September 15, 2014
Record last verified: 2014-09